Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
13.62
-0.27 (-1.94%)
Sep 18, 2026, 4:00 PM EDT - Market closed
Biohaven Employees
Biohaven had 274 employees as of December 31, 2025. The number of employees increased by 18 or 7.03% compared to the previous year.
Employees
274
Change (1Y)
18
Growth (1Y)
7.03%
Revenue / Employee
n/a
Profits / Employee
-$2,141,755
Market Cap
2.06B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 274 | 18 | 7.03% |
| Dec 31, 2024 | 256 | 17 | 7.11% |
| Dec 31, 2023 | 239 | 37 | 18.32% |
| Dec 31, 2022 | 202 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| ADMA Biologics | 647 |
| Recursion Pharmaceuticals | 600 |
| Agios Pharmaceuticals | 540 |
| Vericel | 398 |
| Nuvation Bio | 305 |
| UroGen Pharma | 300 |
| Zenas BioPharma | 167 |
BHVN News
- 1 day ago - Citi views Xenon study pause as positive for Biohaven - TheFly
- 7 days ago - Biohaven Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Biohaven (BHVN) - PRNewsWire
- 8 days ago - Biohaven Stock Is Sinking. Epilepsy Drug Trial Roadblock Is Only the Latest Blow. - Barrons
- 8 days ago - Biohaven clinical hold adds level of uncertainty, says H.C. Wainwright - TheFly
- 8 days ago - Biohaven falls -14.0% - TheFly
- 8 days ago - Impact of Biohaven’s partial FDA hold ‘manageable,’ says Raymond James - TheFly
- 8 days ago - Biohaven down 15% after FDA puts partial clinical hold on BHV-7000 program - TheFly
- 9 days ago - Biohaven falls -15.3% - TheFly